{"id":"https://openalex.org/W7224517784","doi":"https://doi.org/10.1177/11795468261485547","title":"Confounding by Indication in a Propensity-Score-Matched Comparison of PCSK9 Inhibitors Versus GLP-1 Receptor Agonists in Elevated Lipoprotein(a): A Cautionary Real-World Analysis","display_name":"Confounding by Indication in a Propensity-Score-Matched Comparison of PCSK9 Inhibitors Versus GLP-1 Receptor Agonists in Elevated Lipoprotein(a): A Cautionary Real-World Analysis","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7224517784","doi":"https://doi.org/10.1177/11795468261485547"},"language":"en","primary_location":{"id":"doi:10.1177/11795468261485547","doi":"https://doi.org/10.1177/11795468261485547","is_oa":true,"landing_page_url":"https://doi.org/10.1177/11795468261485547","pdf_url":null,"source":{"id":"https://openalex.org/S4210177157","display_name":"Clinical Medicine Insights Cardiology","issn_l":"1179-5468","issn":["1179-5468"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Medicine Insights: Cardiology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1177/11795468261485547","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101731791","display_name":"Abdul Qadeer","orcid":"https://orcid.org/0009-0008-2211-200X","observed_orcids":["https://orcid.org/0009-0008-2211-200X"]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abdul Qadeer","raw_affiliation_strings":["University of Texas Medical Branch"],"raw_orcid":"https://orcid.org/0009-0008-2211-200X","affiliations":[{"raw_affiliation_string":"University of Texas Medical Branch","institution_ids":["https://openalex.org/I55302922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5118619610","display_name":"Mirza Muhammad Hadeed Khawar","orcid":"https://orcid.org/0009-0008-4048-0316","observed_orcids":["https://orcid.org/0009-0008-4048-0316"]},"institutions":[{"id":"https://openalex.org/I125830269","display_name":"Services Institute of Medical Sciences","ror":"https://ror.org/04c1d9r22","country_code":"PK","type":"education","lineage":["https://openalex.org/I125830269"]},{"id":"https://openalex.org/I142016965","display_name":"King Edward Medical University","ror":"https://ror.org/02rrbpf42","country_code":"PK","type":"education","lineage":["https://openalex.org/I142016965"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Mirza Muhammad Hadeed Khawar","raw_affiliation_strings":["Department of Cardiovascular Medicine, King Edward Medical University","Department of Cardiovascular Medicine, Services Institute of Medical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, King Edward Medical University","institution_ids":["https://openalex.org/I142016965"]},{"raw_affiliation_string":"Department of Cardiovascular Medicine, Services Institute of Medical Sciences","institution_ids":["https://openalex.org/I125830269"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040805531","display_name":"Muneeb Khawar","orcid":"https://orcid.org/0009-0005-7051-7413","observed_orcids":["https://orcid.org/0009-0005-7051-7413"]},"institutions":[{"id":"https://openalex.org/I125830269","display_name":"Services Institute of Medical Sciences","ror":"https://ror.org/04c1d9r22","country_code":"PK","type":"education","lineage":["https://openalex.org/I125830269"]},{"id":"https://openalex.org/I142016965","display_name":"King Edward Medical University","ror":"https://ror.org/02rrbpf42","country_code":"PK","type":"education","lineage":["https://openalex.org/I142016965"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Muneeb Khawar","raw_affiliation_strings":["Department of Cardiovascular Medicine, King Edward Medical University","Department of Cardiovascular Medicine, Services Institute of Medical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, King Edward Medical University","institution_ids":["https://openalex.org/I142016965"]},{"raw_affiliation_string":"Department of Cardiovascular Medicine, Services Institute of Medical Sciences","institution_ids":["https://openalex.org/I125830269"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130748206","display_name":"Mohammad Azeem Malik","orcid":"https://orcid.org/0009-0002-4829-8611","observed_orcids":["https://orcid.org/0009-0002-4829-8611"]},"institutions":[{"id":"https://openalex.org/I142016965","display_name":"King Edward Medical University","ror":"https://ror.org/02rrbpf42","country_code":"PK","type":"education","lineage":["https://openalex.org/I142016965"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Mohammad Azeem Malik","raw_affiliation_strings":["Department of Cardiovascular Medicine, King Edward Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, King Edward Medical University","institution_ids":["https://openalex.org/I142016965"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158278241","display_name":"Andrew Forrester","orcid":"https://orcid.org/0009-0008-5385-6773","observed_orcids":["https://orcid.org/0009-0008-5385-6773"]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Forrester","raw_affiliation_strings":["University of Texas Medical Branch"],"raw_orcid":"https://orcid.org/0009-0008-5385-6773","affiliations":[{"raw_affiliation_string":"University of Texas Medical Branch","institution_ids":["https://openalex.org/I55302922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021924788","display_name":"Suhaib Shah","orcid":"https://orcid.org/0009-0003-9386-5395","observed_orcids":["https://orcid.org/0009-0003-9386-5395"]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suhaib Shah","raw_affiliation_strings":["University of Texas Medical Branch"],"raw_orcid":"https://orcid.org/0009-0003-9386-5395","affiliations":[{"raw_affiliation_string":"University of Texas Medical Branch","institution_ids":["https://openalex.org/I55302922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078463762","display_name":"Mohanad Albayyaa","orcid":"https://orcid.org/0000-0003-4185-5294","observed_orcids":["https://orcid.org/0000-0003-4185-5294"]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohanad Albayyaa","raw_affiliation_strings":["University of Texas Medical Branch"],"raw_orcid":"https://orcid.org/0000-0003-4185-5294","affiliations":[{"raw_affiliation_string":"University of Texas Medical Branch","institution_ids":["https://openalex.org/I55302922"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026578587","display_name":"Hani M. Jneid","orcid":"https://orcid.org/0000-0002-8754-358X","observed_orcids":["https://orcid.org/0000-0002-8754-358X"]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hani Jneid","raw_affiliation_strings":["University of Texas Medical Branch"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Medical Branch","institution_ids":["https://openalex.org/I55302922"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2650,"currency":"USD","value_usd":2650},"apc_paid":{"value":2650,"currency":"USD","value_usd":2650},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.8520927,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10845","display_name":"Advanced Causal Inference Techniques","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/confounding-by-indication","display_name":"confounding by indication","score":0.8999999761581421},{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.9589999914169312},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9959999918937683},{"id":"https://openalex.org/keywords/evolocumab","display_name":"evolocumab","score":0.9350000023841858},{"id":"https://openalex.org/keywords/alirocumab","display_name":"alirocumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/inclisiran","display_name":"inclisiran","score":1.0},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.9670000076293945},{"id":"https://openalex.org/keywords/atherosclerotic-cardiovascular-disease","display_name":"atherosclerotic cardiovascular disease","score":0.828000009059906},{"id":"https://openalex.org/keywords/peripheral-arterial-disease","display_name":"peripheral arterial disease","score":0.9350000023841858},{"id":"https://openalex.org/keywords/residual-confounding","display_name":"residual confounding","score":0.7129999995231628},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.6430000066757202},{"id":"https://openalex.org/keywords/statin-initiation","display_name":"statin initiation","score":0.902999997138977},{"id":"https://openalex.org/keywords/drug-class-comparison","display_name":"drug class comparison","score":0.6269999742507935}],"concepts":[{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.7788000106811523},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7523999810218811},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.6780999898910522},{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.6412000060081482},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5763000249862671},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5475000143051147},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5156999826431274},{"id":"https://openalex.org/C119043178","wikidata":"https://www.wikidata.org/wiki/Q320723","display_name":"Covariate","level":2,"score":0.3531999886035919},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.34769999980926514},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33809998631477356},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.33649998903274536},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.33559998869895935},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.31119999289512634},{"id":"https://openalex.org/C2779668873","wikidata":"https://www.wikidata.org/wiki/Q6693756","display_name":"Lower risk","level":3,"score":0.30809998512268066},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.3068000078201294},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.30640000104904175},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.3061000108718872},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2897000014781952},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.2867000102996826},{"id":"https://openalex.org/C2909478654","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Atherosclerotic cardiovascular disease","level":3,"score":0.2644999921321869},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.2637999951839447},{"id":"https://openalex.org/C46762472","wikidata":"https://www.wikidata.org/wiki/Q178648","display_name":"Peripheral","level":2,"score":0.25929999351501465}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1177/11795468261485547","doi":"https://doi.org/10.1177/11795468261485547","is_oa":true,"landing_page_url":"https://doi.org/10.1177/11795468261485547","pdf_url":null,"source":{"id":"https://openalex.org/S4210177157","display_name":"Clinical Medicine Insights Cardiology","issn_l":"1179-5468","issn":["1179-5468"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Medicine Insights: Cardiology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:0adaa386cef748bdb10ab909ef021c78","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/0adaa386cef748bdb10ab909ef021c78","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Medicine Insights: Cardiology, Vol 20 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1177/11795468261485547","doi":"https://doi.org/10.1177/11795468261485547","is_oa":true,"landing_page_url":"https://doi.org/10.1177/11795468261485547","pdf_url":null,"source":{"id":"https://openalex.org/S4210177157","display_name":"Clinical Medicine Insights Cardiology","issn_l":"1179-5468","issn":["1179-5468"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Medicine Insights: Cardiology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1990204315","https://openalex.org/W2098230963","https://openalex.org/W2104355263","https://openalex.org/W2275737843","https://openalex.org/W2425644022","https://openalex.org/W2519510391","https://openalex.org/W2596179513","https://openalex.org/W2899997727","https://openalex.org/W2940327706","https://openalex.org/W2997944188","https://openalex.org/W3092288248","https://openalex.org/W3183857127","https://openalex.org/W3185845820","https://openalex.org/W4388592674"],"related_works":["https://openalex.org/W7203632311","https://openalex.org/W7124767114","https://openalex.org/W4387077699","https://openalex.org/W4400525410","https://openalex.org/W4404921348","https://openalex.org/W4416383244","https://openalex.org/W4415789711","https://openalex.org/W2888537024","https://openalex.org/W7141197904","https://openalex.org/W7155394914"],"abstract_inverted_index":{"Background":[0],"Elevated":[1],"lipoprotein(a)":[2],"is":[3,36,181],"a":[4,65,73,227],"well-established":[5],"cardiovascular":[6,95,221],"risk":[7],"factor":[8],"with":[9,24,54,242],"limited":[10],"therapeutic":[11],"options.":[12],"Both":[13],"PCSK9":[14,66,136,177,204],"inhibitors":[15],"and":[16,127,146,161,207],"GLP-1":[17,74,173],"receptor":[18,75,174],"agonists":[19,175],"are":[20],"used":[21,45],"in":[22,91,109,134,148,192,202,211],"patients":[23,88,114],"elevated":[25,55],"Lp(a),":[26],"yet":[27],"any":[28],"observational":[29],"comparison":[30,238],"between":[31,239],"these":[32,169],"two":[33],"drug":[34,240],"classes":[35,241],"highly":[37],"vulnerable":[38],"to":[39,51,143,218],"confounding":[40,187],"by":[41,188],"indication.":[42,189],"Methods":[43],"We":[44],"the":[46,135,149,195,203],"TriNetX":[47],"U.S.":[48],"Collaborative":[49],"Network":[50],"identify":[52],"adults":[53],"Lp(a)":[56],"(>125":[57],"nmol/L":[58],"or":[59,70,72],">50":[60],"mg/dL)":[61],"initiated":[62],"on":[63,154,232],"either":[64],"inhibitor":[67,137,205],"(evolocumab,":[68],"alirocumab,":[69],"inclisiran)":[71],"agonist":[76],"within":[77],"one":[78],"year":[79],"of":[80,113,123,151,168,186,198],"diagnosis.":[81],"After":[82,105],"1:1":[83],"propensity":[84],"score":[85],"matching,":[86,106],"1,594":[87],"were":[89,97,131],"included":[90],"each":[92],"cohort.":[93],"One-year":[94],"outcomes":[96],"compared":[98],"using":[99],"Cox":[100],"proportional":[101],"hazards":[102],"regression.":[103],"Results":[104],"MACE-3":[107],"occurred":[108,147],"11.3%":[110],"versus":[111],"9.1%":[112],"(HR":[115],"1.25,":[116],"95%":[117],"CI":[118],"1.01\u20131.56).":[119],"Numerically":[120],"higher":[121],"rates":[122],"MACE-4,":[124],"incident":[125],"ASCVD,":[126],"peripheral":[128],"artery":[129],"disease":[130],"also":[132],"observed":[133],"arm.":[138],"These":[139],"associations":[140],"ran":[141],"opposite":[142],"randomized-trial":[144],"evidence":[145],"presence":[150],"residual":[152],"imbalance":[153,191],"body-mass":[155,193],"index":[156],"(standardized":[157],"difference":[158],"0.647),":[159],"HbA1c,":[160],"total":[162],"cholesterol.":[163],"Conclusions":[164],"A":[165],"na\u00efve":[166],"reading":[167],"results":[170],"would":[171],"suggest":[172],"outperform":[176],"inhibitors.":[178],"This":[179,223],"interpretation":[180],"almost":[182],"certainly":[183],"an":[184],"artifact":[185],"Residual":[190],"index,":[194],"coherent":[196],"excess":[197],"all":[199],"atherosclerotic":[200],"endpoints":[201],"arm,":[206],"lower":[208],"statin":[209],"initiation":[210],"that":[212,215],"arm":[213],"indicate":[214],"matching":[216,231],"failed":[217],"equalize":[219],"baseline":[220],"severity.":[222],"analysis":[224],"serves":[225],"as":[226],"cautionary":[228],"case:":[229],"propensity-score":[230],"measured":[233],"covariates":[234],"cannot":[235],"support":[236],"causal":[237],"such":[243],"divergent":[244],"prescribing":[245],"indications.":[246]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-30T00:00:00"}